drugset / Trial / NCT00801957

Equivalence of the Response to Vaccination of Tacrolimus Ointment to a Steroid Ointment Regimen in Children With Atopic Dermatitis

NCT00801957

Phase 2 Completed 260 enrolled Astellas Pharma Inc
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Seven-month study in pediatric patients (2-11 years) with moderate to severe AD who were considered to benefit from vaccination to prevent invasive disease caused by Neisseria meningitides serogroup C.

Timeline

Start
2003-03
Primary completion
2004-11
Completion
2004-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hydrocortisone Other / unclassified 1 % Topical
Comparator Hydrocortisone Butyrate Unknown 0.1 % Topical
Subject Tacrolimus Small molecule 0.03 % Topical
Background AC VAX Vaccine Intramuscular
Background Meningitec Vaccine Intramuscular

Indications